Suppr超能文献

恶性疟原虫抗疟药耐药基因:综述。

Antimalarial drugs resistance genes of Plasmodium falciparum: a review.

机构信息

Laboratoire de Biochimie et Immunologie Appliquées (LABIA), Département de Biochimie-Microbiologie, Université Joseph Ki-Zerbo (UJKZ), Burkina Faso.

Ecole de Santé Sciences Nouvelles (ESSN), Ouagadougou, Burkina Faso.

出版信息

Ann Parasitol. 2022;68(2):215-225. doi: 10.17420/ap6802.427.

Abstract

Malaria remains the most common parasitic disease on the planet, with 229 million cases and 409,000 deaths worldwide in 2019, including 274,030 children under the age of 5. It is one of the most important infectious diseases in the world and its control is compromised by the spread of the parasite's resistance to antimalarial drugs. This study aims to review the literature of resistant Plasmodium falciparum genes over the past twenty years. One hundred and five (105) articles were collected and read while the resistance of P. falciparum was being studied. Several P. falciparum gene resistances antimalarial drugs were discovered over the past twenty years. The most recent one is the Kelch13 gene of P. falciparum (Pfkelch13) which has showed resistance to artemisinin in Asia. In Africa, this gene represents a potential candidate for resistance to artemisinin, although no resistance was reported.

摘要

疟疾仍然是地球上最常见的寄生虫病,2019 年全球有 2.29 亿例病例和 40.9 万人死亡,其中包括 274030 名 5 岁以下儿童。它是世界上最重要的传染病之一,其控制受到寄生虫对抗疟药物耐药性传播的影响。本研究旨在回顾过去二十年来耐疟原虫基因的文献。在研究疟原虫耐药性的过程中,共收集并阅读了 105 篇文章。过去二十年来,发现了几种耐疟原虫基因抗疟药物。最近的一个是疟原虫 Kelch13 基因(Pfkelch13),它对亚洲的青蒿素表现出耐药性。在非洲,该基因代表了对青蒿素耐药的潜在候选基因,尽管尚未报告有耐药性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验